Glen Burkhardt is SVP of Human Resources of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 23, 2022, when has been sold 11,248 shares (Common Stock) at a price of $0.79 per share, resulting in proceeds of $8,886. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Glen Burkhardt Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2022
SELL
Open market or private sale
$8,886 $0.79 p/Share
11,248 Reduced 100.0%
0 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
$7,649 $0.68 p/Share
11,248 Added 50.0%
11,248 Common Stock
Nov 19 2021
SELL
Open market or private sale
$13,665 $2.37 p/Share
5,766 Reduced 100.0%
0 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$11,590 $2.01 p/Share
5,766 Added 50.0%
5,766 Common Stock
May 20 2021
SELL
Open market or private sale
$12,538 $3.29 p/Share
3,811 Reduced 100.0%
0 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
$10,671 $2.8 p/Share
3,811 Added 50.0%
3,811 Common Stock
Nov 23 2020
SELL
Open market or private sale
$12,065 $3.45 p/Share
3,497 Reduced 100.0%
0 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
$10,491 $3.0 p/Share
3,497 Added 50.0%
3,497 Common Stock
GB

Glen Burkhardt

SVP of Human Resources
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Track Activities on PHAS